X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (300) 300
Patent (45) 45
Book Review (31) 31
Publication (22) 22
Book Chapter (5) 5
Conference Proceeding (5) 5
Book / eBook (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (187) 187
humans (149) 149
oncology (111) 111
male (76) 76
animals (75) 75
female (70) 70
cancer (65) 65
middle aged (58) 58
aged (49) 49
mice (46) 46
adult (42) 42
chemistry (35) 35
metallurgy (35) 35
neoplasms - drug therapy (33) 33
tumors (32) 32
cell biology (31) 31
mutation (27) 27
angiogenesis (26) 26
chemotherapy (26) 26
beer (25) 25
biochemistry (25) 25
enzymology (25) 25
human necessities (25) 25
hygiene (25) 25
medical or veterinary science (25) 25
microbiology (25) 25
mutation or genetic engineering (25) 25
preparations for medical, dental, or toilet purposes (25) 25
spirits (25) 25
vinegar (25) 25
wine (25) 25
biochemistry & molecular biology (24) 24
research (24) 24
specific therapeutic activity of chemical compounds ormedicinal preparations (24) 24
breast-cancer (23) 23
endothelial growth-factor (21) 21
mice, inbred balb c (21) 21
neoplasms - pathology (21) 21
treatment outcome (21) 21
compositions or test papers therefor (20) 20
condition-responsive control in microbiological orenzymological processes (20) 20
measuring or testing processes involving enzymes, nucleicacids or microorganisms (20) 20
processes of preparing such compositions (20) 20
expression (19) 19
antineoplastic agents - therapeutic use (17) 17
organic chemistry (17) 17
therapy (17) 17
aged, 80 and over (16) 16
care and treatment (16) 16
dose-response relationship, drug (16) 16
peptides (16) 16
carcinoma (15) 15
metastasis (15) 15
analysis (14) 14
colorectal neoplasms - pathology (14) 14
prognosis (14) 14
antineoplastic agents - pharmacology (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
cell line, tumor (13) 13
pharmacology & pharmacy (13) 13
bevacizumab (12) 12
cell lung-cancer (12) 12
growth (12) 12
in-vivo (12) 12
neoplasms - metabolism (12) 12
tumor angiogenesis (12) 12
cancer research (11) 11
colorectal cancer (11) 11
gene expression regulation, neoplastic (11) 11
genetic aspects (11) 11
genomics (11) 11
health aspects (11) 11
medical research (11) 11
mice, inbred c57bl (11) 11
neoplasms - genetics (11) 11
precision medicine (11) 11
risk factors (11) 11
young adult (11) 11
abridged index medicus (10) 10
angiogenesis inhibitors - therapeutic use (10) 10
antineoplastic agents - adverse effects (10) 10
maximum tolerated dose (10) 10
medicine, research & experimental (10) 10
neoplasm metastasis (10) 10
neoplasms - therapy (10) 10
neovascularization (10) 10
neovascularization, pathologic (10) 10
patients (10) 10
protein (10) 10
rats (10) 10
cancer therapies (9) 9
clinical trials (9) 9
disease progression (9) 9
identification (9) 9
inhibition (9) 9
medicine & public health (9) 9
mouse (9) 9
quality of life (9) 9
surgery (9) 9
time factors (9) 9
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (337) 337
French (24) 24
German (13) 13
Dutch (7) 7
Finnish (2) 2
Swedish (2) 2
Danish (1) 1
Norwegian (1) 1
Portuguese (1) 1
Spanish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2014, Volume 111, Issue 20, pp. 7313 - 7318
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2016, Volume 11, Issue 2, pp. e0149405 - e0149405
Journal Article
BBA - Reviews on Cancer, ISSN 0304-419X, 2009, Volume 1796, Issue 1, pp. 1 - 4
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2009, Volume 360, Issue 6, pp. 563 - 572
Capecitabine, oxaliplatin, and bevacizumab are standard treatment for metastatic colorectal cancer. This trial tested whether adding cetuximab to this... 
CAPECITABINE | GROWTH-FACTOR RECEPTOR | MEDICINE, GENERAL & INTERNAL | PLUS OXALIPLATIN | FINAL REPORT | PHASE-III | COMBINATION CHEMOTHERAPY | IRINOTECAN | RANDOMIZED CONTROLLED-TRIAL | 1ST-LINE THERAPY | FLUOROURACIL | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Capecitabine | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Bevacizumab | Antibodies, Monoclonal, Humanized | Organoplatinum Compounds - administration & dosage | Receptor, Epidermal Growth Factor - metabolism | Fluorouracil - administration & dosage | Neoplasm Metastasis - drug therapy | Colorectal Neoplasms - drug therapy | Treatment Failure | Aged, 80 and over | Adult | Female | Cetuximab | Receptor, Epidermal Growth Factor - immunology | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Proto-Oncogene Proteins - genetics | Disease-Free Survival | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quality of Life | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Mutation | Colorectal Neoplasms - pathology | Deoxycytidine - analogs & derivatives | Care and treatment | Chemotherapy | Usage | Health aspects | Colorectal cancer | Cancer | Clinical trials | Cancer therapies | Medical treatment | Committees | Index Medicus | Abridged Index Medicus
Journal Article
Cell Reports, ISSN 2211-1247, 03/2016, Volume 14, Issue 10, pp. 2281 - 2288
Journal Article
Cancer Cell, ISSN 1535-6108, 2008, Volume 14, Issue 3, pp. 263 - 273
Several hypotheses have been proposed to explain how antiangiogenic drugs enhance the treatment efficacy of cytotoxic chemotherapy, including impairing the... 
CELLCYCLE | BREAST-CANCER | LUNG-CANCER | RECRUITMENT | THERAPY | ONCOLOGY | VEGF | CHEMOKINE | GROWTH-FACTOR | TUMOR ANGIOGENESIS | NEOVASCULARIZATION | METRONOMIC CHEMOTHERAPY | CELL BIOLOGY | Paclitaxel - pharmacology | Apoptosis - drug effects | Humans | Melanoma, Experimental - drug therapy | Antibodies, Monoclonal - therapeutic use | Deoxycytidine - pharmacology | Antineoplastic Agents - therapeutic use | Deoxycytidine - therapeutic use | Neoplasms - blood | Angiogenesis Inhibitors - therapeutic use | Bone Marrow Cells - drug effects | Female | Antineoplastic Agents - pharmacology | Drug Therapy, Combination | Antibodies, Monoclonal - pharmacology | Mice, Inbred C57BL | Bone Marrow Cells - pathology | Vascular Endothelial Growth Factor A - blood | Angiogenesis Inhibitors - pharmacology | Melanoma, Experimental - pathology | Carcinoma, Lewis Lung - blood | Breast Neoplasms - drug therapy | Paclitaxel - therapeutic use | Carcinoma, Lewis Lung - drug therapy | Neoplasms - drug therapy | Animals | Tumor Burden - drug effects | Breast Neoplasms - pathology | Chemokine CXCL12 - blood | Breast Neoplasms - blood | Carcinoma, Lewis Lung - pathology | Stem Cells - drug effects | Stem Cells - pathology | Cell Proliferation - drug effects | Melanoma, Experimental - blood | Mice | Mice, Inbred BALB C | Endothelial Cells - pathology | Neoplasms - pathology | Deoxycytidine - analogs & derivatives | Endothelial Cells - drug effects | Antimitotic agents | Chemotherapy | Antineoplastic agents | Antitank weapons | Cancer | Tumors | Endothelium | Index Medicus
Journal Article
Nature Methods, ISSN 1548-7091, 2009, Volume 6, Issue 7, pp. 474 - 476
Journal Article
Trials, ISSN 1745-6215, 2012, Volume 13, Issue 1, pp. 230 - 230
For esophageal cancer patients, radical esophagolymphadenectomy is the cornerstone of multimodality treatment with curative intent. Transthoracic esophagectomy... 
SURGERY | SURVIVAL | MEDICINE, RESEARCH & EXPERIMENTAL | LIMITED TRANSHIATAL RESECTION | ADENOCARCINOMA | CHEMORADIOTHERAPY | OUTCOMES | CARCINOMA | BENEFITS | Hospital Costs | Lymph Node Excision | Esophagectomy - adverse effects | Adenocarcinoma - pathology | Laparoscopy - mortality | Esophagectomy - mortality | Carcinoma, Squamous Cell - pathology | Humans | Laparoscopy - economics | Middle Aged | Clinical Protocols | Thoracoscopy - adverse effects | Carcinoma, Squamous Cell - surgery | Esophagectomy - methods | Postoperative Complications - mortality | Robotics | Esophageal Neoplasms - pathology | Young Adult | Surgery, Computer-Assisted - adverse effects | Netherlands | Carcinoma, Squamous Cell - mortality | Laparoscopy - adverse effects | Time Factors | Esophageal Neoplasms - surgery | Carcinoma, Squamous Cell - economics | Esophagectomy - economics | Aged, 80 and over | Esophageal Neoplasms - mortality | Adult | Surgery, Computer-Assisted - economics | Esophageal Neoplasms - economics | Length of Stay | Hospital Mortality | Risk Factors | Surgery, Computer-Assisted - mortality | Treatment Outcome | Thoracoscopy - economics | Cost-Benefit Analysis | Thoracoscopy - mortality | Adolescent | Quality of Life | Aged | Adenocarcinoma - economics | Neoplasm Staging | Research Design | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Care and treatment | Mortality | Clinical trials | Medical care | Laparoscopic surgery | Laparoscopy | Research | Comparative analysis | Health aspects | Robots | Esophageal cancer | Quality management | Index Medicus
Journal Article
Cell Reports, ISSN 2211-1247, 06/2016, Volume 16, Issue 1, pp. 263 - 277
The therapeutic landscape of melanoma is improving rapidly. Targeted inhibitors show promising results, but drug resistance often limits durable clinical... 
Journal Article
Cancer Cell, ISSN 1535-6108, 2011, Volume 20, Issue 3, pp. 370 - 383
Journal Article
Human Mutation, ISSN 1059-7794, 05/2010, Volume 31, Issue 5, pp. 521 - 537
Mutations in the von Hippel-Lindau (VHL) gene are responsible for VHL disease, congenital polycythemia, and are found in many sporadic tumor types as well.... 
Von Hippel-Lindau | Pheochromocytoma | VHL | HIF | Hemangioblastoma | Kidney cancer | DEPENDENT PROBE AMPLIFICATION | GENOTYPE-PHENOTYPE CORRELATIONS | <